Login

Interview Michel Finance, Director, Theradiag 00:00:00

Share On Facebook Share On Twitter

Interview Michel Finance, Director, Theradiag

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
A major player in private equity and infrastructure|Andrew Lockhart,Partner, Metrics Credit Partners
00:00:00
Görgen Nilsson, CEO, ScandiDos
00:10:00
Driving Innovation and Equity: Jeremiah Gordon on Growth Funds and Impact Investing | General Counsel, CapitalG
00:10:00
Drake Dettore Shares Insights on Landing an Investment Banking Role at Bryant Park Capital|Drake Dettore, Investment Banking Analyst,Bryant Park Capital
00:10:00
B2B software focused venture fund, program, and community with offices in San Francisco|Jonah Midanik,COO & General Partner,Forum Ventures (fka Accelprise)
00:10:00
Discover a Personalized Approach to Trust Services | Robert L. Riedl, CEO , Endowment Wealth Management, Inc.
00:10:00
Leading early-stage venture capital firm providing pre-seed and seed capital to technology|Peter Goldberg,Founder and Partner,PLG Ventures
00:10:00
Focused on early stage growth capital late stage and startup financing|Albert Wenger,Managing Partner,Union Square Ventures
00:10:00
A Discussion on Market Dynamics with the CEO of Aditya Birla | A. Balasubramanian, CEO , Aditya Birla Sun Life AMC Limited.
00:10:00
How Divya Galani Helped Optimize Assays with BioTek Instruments in Jordan.
00:10:00
Copper Mountain Mine: Unveiling the Mining Process | Patrick Merrin - CEO of Copper Mountain Mining Corp
00:10:00
Finding Balance in Investment: Insights from Naveen Venkataramani of Wellington Management | Naveen Venkataramani - Equity Portfolio Manager, Wellington Management

© 2026 Nehu